MIMEDX to Participate in Upcoming Investor Conferences

GlobeNewswire

04 Dec 2024

MARIETTA, Ga., Dec. 04, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:

Mizuho Health Care Conference
Wednesday, December 11, 2024
1:1 sessions | New York, NY

Northland Growth Conference
Thursday, December 12, 2024
1:1 sessions | Virtual

Stifel MedTech West Coast Bus Tour
Thursday, December 12, 2024
1:1 sessions | Palo Alto, CA

Investors interested in meeting with senior management at these events may contact their respective Mizuho, Northland Capital or Stifel representative.

About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact:

Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2488196004"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2488196004\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2488196004?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Au3CzXpVwHF6Utyte.qmAg--~B/aD0xNDQ5O3c9MzYzMzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/81f79a0e81798ccaab518c1165a11413","is_english":true,"pubTime":"2024-12-04 21:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2488196004","market":"us","top_or_hot":-1,"title":"MIMEDX to Participate in Upcoming Investor Conferences","media":"GlobeNewswire","content":"<html><body><img hspace=\"5\" src=\"https://s1.yimg.com/uu/api/res/1.2/ClGp1ZDIL9Fg0GkQKjmbRA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/globenewswire.com/68d7327cd549087791cd3ae0959a08d8\" title=\"MIMEDX.png\" vspace=\"5\"/>\n<p>MARIETTA, Ga., Dec. 04, 2024 (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/MDXG\">MiMedx Group, Inc.</a> (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:</p>\n<p><strong>Mizuho Health Care Conference</strong><br/>Wednesday, December 11, 2024<br/>1:1 sessions | New York, NY<br/><br/></p>\n<p><strong>Northland Growth Conference</strong><br/>Thursday, December 12, 2024<br/>1:1 sessions | Virtual<br/><br/></p>\n<p><strong>Stifel MedTech West Coast Bus Tour</strong><br/>Thursday, December 12, 2024<br/>1:1 sessions | Palo Alto, CA<br/><br/></p>\n<p>Investors interested in meeting with senior management at these events may contact their respective Mizuho, Northland Capital or Stifel representative.</p>\n<p><strong>About MIMEDX</strong><br/>MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit <u>www.mimedx.com.</u><br/></p>\n<p><strong>Contact:</strong></p>\n<p>Matt Notarianni<br/>Investor Relations<br/>470-304-7291<br/>mnotarianni@mimedx.com<br/><br/><br/></p>\n<br/></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MIMEDX to Participate in Upcoming Investor Conferences</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMIMEDX to Participate in Upcoming Investor Conferences\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-04 21:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/mimedx-participate-upcoming-investor-conferences-130000499.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MARIETTA, Ga., Dec. 04, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following ...</p>\n\n<a href=\"https://finance.yahoo.com/news/mimedx-participate-upcoming-investor-conferences-130000499.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDXG","symbol_name":"MiMedx Group, Inc.","start_time":0,"source_url":"https://finance.yahoo.com/news/mimedx-participate-upcoming-investor-conferences-130000499.html","article_id":"2488196004","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Au3CzXpVwHF6Utyte.qmAg--~B/aD0xNDQ5O3c9MzYzMzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/81f79a0e81798ccaab518c1165a11413"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2488196004","pubTimestamp":1733317200,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"MARIETTA, Ga., Dec. 04, 2024  -- MiMedx Group, Inc.   today announced that members of its senior management will participate in the following investor conferences:. Northland Growth ConferenceThursday, December 12, 20241:1 sessions | Virtual. Stifel MedTech West Coast Bus TourThursday, December 12, 20241:1 sessions | Palo Alto, CA. Investors interested in meeting with senior management at these events may contact their respective Mizuho, Northland Capital or Stifel representative.About MIMEDXMIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDXG":"MiMedx Group, Inc.","BK4139":"生物科技"},"translate_title":"MIMEDX将参加即将举行的投资者会议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDXG":0.9},"content_text":"MARIETTA, Ga., Dec. 04, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:\nMizuho Health Care ConferenceWednesday, December 11, 20241:1 sessions | New York, NY\nNorthland Growth ConferenceThursday, December 12, 20241:1 sessions | Virtual\nStifel MedTech West Coast Bus TourThursday, December 12, 20241:1 sessions | Palo Alto, CA\nInvestors interested in meeting with senior management at these events may contact their respective Mizuho, Northland Capital or Stifel representative.\nAbout MIMEDXMIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.\nContact:\nMatt NotarianniInvestor Relations470-304-7291mnotarianni@mimedx.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}